参考文献/References:
［1］国家中医药管理局. 关于印发医疗机构医用耗材管理办法（试行）的通知［EB/OL］.(2019-06-21) ［2021-10-21］.http://bgs.satcm.gov.cn/zhengcewenjian/2019-06-21/10070.html.
［2］肖月,邱英鹏,赵羽西,等.价值医疗视角下高值医用耗材的综合治理改革［J］.中国医院管理,2021,41(3):1-5.
［3］邱英鹏,赵翔,肖月,等.高值医用耗材定义与治理内涵研究［J］.中国卫生质量管理,2021,28(5):1-3，11.
［4］金春林,王海银,孙辉,等.价值医疗的概念、实践及其实现路径［J］.卫生经济研究,2019,36(2):6-8.
［5］GARRISON LP, NEUMANN PJ, WILLKE RJ, et al. A health economics approach to US value assessment frameworks—summary and recommendations of the ISPOR special task force report ［J］. Value in Health,2018,21(2):161-165.
［6］隋宾艳,齐雪然.英国NICE卫生技术评估研究决策转化机制及对我国的启示［J］.中国卫生政策研究,2015,8(7):74-78.
［7］吕兰婷,余浏洁.英国NICE医用耗材准入流程及启示［J］.中国医疗保险,2019(10):77-80.
［8］RAWLINS MD, CULYER AJ. National Institute for Clinical Excellence and its value judgments［J］. BMJ, 2004,329(7459):224-227.
［9］Medical technologies evaluation programme process guide［EB/OL］. (2017-08-21)［2022-03-05］. https://www.nice.org.uk/process/pmg34/chapter/publishing-medical-technologies-guidance#timeline-2.
［10］邱英鹏,赵羽西,赵翔,等.澳大利亚假体类高值医用耗材医保准入管理经验及启示［J］.中国卫生质量管理,2021,28(5):12-15.
［11］Prostheses List［EB/OL］. (2022-03-01)［2022-03-15］. https://www.health.gov.au/resources/publications/prostheses-list.
［12］谭华伟,焦培峻,王彩云.高值医用耗材医保准入与支付机制的国际经验与中国实践［J］.卫生经济研究,2021,38(3):44-49.
［13］LEE SS, SALOLE E.Medical device reimbursement coverage and pricing rules in Korea: current practice and issues with access to innovation［J］.Value in Health,2014,17(4):476-481.
［14］丁锦希,黄新锋,李伟,等. 域外高值医用耗材医保准入制度研究及我国启示［J］. 上海医药,2021,42(1):65-69.
［15］明坚, 魏艳, 何运臻,等. 医疗器械和诊断产品的卫生技术评估路在何方：基于国际经验的启示［J］. 中国医疗保险, 2021(6):69-74.
［16］孙黄颖,孙巧,李弯,等.建立医用耗材综合价值评估指标体系初探［J］.中国医疗保险,2021(11):34-38.
相似文献/References:
[1]邱英鹏赵翔肖月赵羽西.高值医用耗材定义与治理内涵研究[J].中国卫生质量管理,2021,28(05):001.[doi:10.13912/j.cnki.chqm.2021.28.5.01
]
QIU Yingpeng,ZHAO Xiang,XIAO Yue.The Definition and Governance Connotation of High Value Medical Consumables[J].Chinese Health Quality Management,2021,28(06):001.[doi:10.13912/j.cnki.chqm.2021.28.5.01
]
[2]邱英鹏李理然赵羽西肖月.人工晶体卫生技术评估方法学分析及启示[J].中国卫生质量管理,2021,28(05):004.[doi:10.13912/j.cnki.chqm.2021.28.5.02
]
QIU Yingpeng,LI Liran,ZHAO Yuxi.Methodological Analysis and Implications of Health Technology Assessment of Intraocular Lens[J].Chinese Health Quality Management,2021,28(06):004.[doi:10.13912/j.cnki.chqm.2021.28.5.02
]
[3]赵羽西邱英鹏肖月.英国高值医用耗材准入及招采管理经验分享：以英格兰为例[J].中国卫生质量管理,2021,28(05):008.[doi:10.13912/j.cnki.chqm.2021.28.5.03
]
ZHAO Yuxi,QIU Yingpeng,XIAO Yue.Access and Procurement Management of High Value Medical Consumables in the UK: A Case Study of England[J].Chinese Health Quality Management,2021,28(06):008.[doi:10.13912/j.cnki.chqm.2021.28.5.03
]
[4]邱英鹏赵羽西赵翔肖月.澳大利亚假体类高值医用耗材医保准入管理经验及启示[J].中国卫生质量管理,2021,28(05):012.[doi:10.13912/j.cnki.chqm.2021.28.5.04
]
QIU Yingpeng,ZHAO Yuxi,ZHAO Xiang.Experience in Medical Insurance Access Management of Prosthetic High Value Medical Consumables in Australia and Its Implications[J].Chinese Health Quality Management,2021,28(06):012.[doi:10.13912/j.cnki.chqm.2021.28.5.04
]
[5]王悦刘莉孙驰蒋筠宋辉郑晨陈勇张云峰.提高高值医用耗材管理信息追溯覆盖率[J].中国卫生质量管理,2023,30(04):082.[doi:10.13912/j.cnki.chqm.2023.30.4.20
]
WANG Yue,LIU Li,SUN Chi.Improving the Management Information Traceability Coverage Rate of High Value Medical Consumables[J].Chinese Health Quality Management,2023,30(06):082.[doi:10.13912/j.cnki.chqm.2023.30.4.20
]
[6]林海蓓刘昕罗莉郑蕴欣罗力金春林王海银.基于多准则决策分析的公立医院高值医用耗材准入指标及权重研究[J].中国卫生质量管理,2023,30(11):064.[doi:10.13912/j.cnki.chqm.2023.30.11.14
]
LIN Haibei,LIU Xin,LUO Li.Access Indicators and Weights of High-Value Medical Consumables in Public Hospitals Based on Multi-Criteria Decision Analysis[J].Chinese Health Quality Management,2023,30(06):064.[doi:10.13912/j.cnki.chqm.2023.30.11.14
]